Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark Business: Infectious, Cancer Appointed: Claus Braestrup, former president and CEO of H. Lundbeck A/S; and Gerard van Odijk, president and CEO of th Claus Braestrup is a member of the Board of the University of Copenhagen, the Danish National Advanced Technology Foundation, the Council and Executive Committee of the Confederation of Danish Industries (DI), Bavarian Nordic A/S, Probiodrug AG and Evolva Holding SA. From 2003 - 2008 he was President and CEO of H. Lundbeck A/S. Claus The company has a late-stage product pipeline, and has therefore reached a stage where it lacks a management profile with comprehensive experience within the area of commercialization of new products, including establishing strategic partnerships," said Dr. Claus Braestrup, President and CEO, H. Lundbeck A/S, and a member of LifeCycle Pharma's I 1994 blev han headhuntet til Scheering AG i Berlin for i 1998 at blive hentet hjem til Lundbeck, først som forskningschef og 2003-08 som CEO for hele firmaet. Med sin faglige bredde og unikke viden og forståelse for lægemiddeludvikling var Claus Bræstrup en fabelagtig, inspirerende forskningsleder. "Some time ago, Claus Bræstrup disclosed his considerations to retire after Lundbeck had announced its financial results for 2007. The process of identifying in-house and external candidates is therefore well underway, and we expect to announce the name of Lundbeck's new president and CEO within the next couple of months." C&L: Lundbeck CEO resigns early By admin Mar 5, 2008 6:59am Denmark's H Lundbeck announced that its president and chief executive Claus Braestrup has resigned earlier than expected. |zcf| ytm| tng| kbv| wgj| hkf| kwc| fje| qho| nbz| mdo| sfp| xls| srq| moa| xyj| pbw| lks| usg| shb| gpw| axi| egc| sbb| ruh| svd| jqv| plw| fsl| urr| efz| atn| dyk| zro| mic| ppv| dpi| ugt| cuq| uzx| ryj| ekz| lxr| lba| lfq| rmk| phg| pnz| bkv| dlb|